Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With Hyperphosphatemia

Clinical trial NCT00530114 · COMPLETED

Trial details

NCT number: NCT00530114
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

End Stage Renal Disease Chronic Kidney Disease Hyperphosphatemic Kidney Disease

Start date: 2008-03-01
Primary completion: 2008-11-01
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.